The Molecular Diagnostics section performs pathogen detection using a wide range of sensitive molecular diagnostic methods, including highly sensitive and specific conventional and real-time PCRs; immunohistochemistry and in-situ hybridization for fresh and formalin-fixed tissues; immunofluoresence for detection of pathogens in body fluids, cytological preparations and fecal parasites; and 16s PCR and sequencing for identification of bacteria from cultures.
Test development draws on the diverse expertise of our pathobiology research group, who not only have expertise in the laboratory setting, but have backgrounds in management of the species involved. This ensures results are interpreted by leaders in the field, with a deep understanding of the test, the pathogen it is detecting, and its impact on animal management.
Our greatest expertise lies in detection of pathogens associated with companion animal and wildlife species, and we welcome the opportunity to discuss development of new assays for support of animal management or research in these specialist areas.
|Test Category||Test Name|
|Immunofluorescence||FCoV (FIPV) (cytospin/effusion)
FeLV (EDTA blood)
FIV (EDTA blood)
|Immunohistochemistry (FFPE tissue)||Chlamydia
Feline Herpes Virus
|Real-time PCR (swab/tissue)||Chlamydia pecorum
|PCR and sequencing*||Bacterial ID 16s
Fungal ID 18s
|Serology (serum)||Cryptococcus Ag LCAT
Cryptococcus Ag lateral flow ELISA
|Faecal protozoal detection*||Cryptosporidium, Giardia, T. fetus
(culture and immunofluorescence)
T. fetus (culture)
|Associated Profiles||Koala Chlamydia PCR
(ocular and urogenital swabs, C. pecorum and
(Koala Chlamydial PCR, Cryptococcus Ag ELISA)
Koala Health Profile (FBC and biochemistry)
Note: For tests marked *, contact lab before submission!
Contact: Section Head, Dr Damien Higgins